APYX Financial Statements

Balance sheet, income statement, cash flow, and dividends for Apyx Medical Corp (APYX).


$54.74M Market Cap.

As of 03/13/2025 5:00 PM ET (MRY) • Disclaimer

APYX Market Cap. (MRY)


APYX Shares Outstanding (MRY)


APYX Assets (MRY)


Total Assets

$64.84M

Total Liabilities

$50.51M

Total Investments

$0

APYX Income (MRY)


Revenue

$48.10M

Net Income

-$23.46M

Operating Expense

$48.20M

APYX Cash Flow (MRY)


CF Operations

-$18.05M

CF Investing

-$722.00K

CF Financing

$6.75M

APYX Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

APYX Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$64,842,000 (-18.17%)

$79,240,000 (53.05%)

$51,775,000 (-24.66%)

$68,721,000 (-7.27%)

Assets Current

$56,440,000 (-19.79%)

$70,362,000 (63.74%)

$42,972,000 (-29.25%)

$60,737,000 (-8.10%)

Assets Non-Current

$8,402,000 (-5.36%)

$8,878,000 (0.85%)

$8,803,000 (10.26%)

$7,984,000 (-0.47%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$14,210,000 (-46.78%)

$26,701,000 (-28.95%)

$37,582,000 (-30.02%)

$53,704,000 (-15.72%)

Property Plant & Equipment Net

$6,738,000 (-5.71%)

$7,146,000 (-5.80%)

$7,586,000 (10.36%)

$6,874,000 (-4.73%)

Cash & Equivalents

$31,741,000 (-27.29%)

$43,652,000 (328.30%)

$10,192,000 (-66.98%)

$30,870,000 (-26.35%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$1,118,000 (-10.27%)

$1,246,000 (-11.51%)

$1,408,000 (6.42%)

$1,323,000 (113.04%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$7,564,000 (-23.77%)

$9,923,000 (-15.89%)

$11,797,000 (74.05%)

$6,778,000 (67.32%)

Trade & Non-Trade Receivables

$15,480,000 (10.15%)

$14,053,000 (31.32%)

$10,701,000 (-20.86%)

$13,521,000 (39.77%)

Trade & Non-Trade Payables

$2,615,000 (-3.58%)

$2,712,000 (1.61%)

$2,669,000 (1.44%)

$2,631,000 (74.12%)

Accumulated Retained Earnings (Deficit)

-$77,911,000 (-43.09%)

-$54,448,000 (-52.37%)

-$35,735,000 (-184.72%)

-$12,551,000 (-578.86%)

Tax Assets

$0 (0%)

$0 (0%)

$7,545,000 (-1.27%)

$7,642,000 (-0.16%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$38,764,000 (0.68%)

$38,501,000 (4736.81%)

$796,000 (160.98%)

$305,000 (-54.88%)

Debt Current

$355,000 (-3.27%)

$367,000 (45.06%)

$253,000 (-11.85%)

$287,000 (-21.15%)

Debt Non-Current

$38,409,000 (0.72%)

$38,134,000 (6922.84%)

$543,000 (2916.67%)

$18,000 (-94.23%)

Total Liabilities

$50,507,000 (-3.46%)

$52,318,000 (274.18%)

$13,982,000 (-4.96%)

$14,712,000 (43.50%)

Liabilities Current

$10,721,000 (-15.85%)

$12,740,000 (7.51%)

$11,850,000 (-10.26%)

$13,205,000 (44.27%)

Liabilities Non-Current

$39,786,000 (0.53%)

$39,578,000 (1756.38%)

$2,132,000 (41.47%)

$1,507,000 (37.12%)

APYX Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$48,102,000 (-8.11%)

$52,349,000 (17.61%)

$44,510,000 (-8.26%)

$48,517,000 (75.08%)

Cost of Revenue

$18,742,000 (0.82%)

$18,590,000 (20.88%)

$15,379,000 (3.10%)

$14,916,000 (46.14%)

Selling General & Administrative Expense

$43,125,000 (-11.75%)

$48,866,000 (1.49%)

$48,149,000 (10.11%)

$43,728,000 (29.88%)

Research & Development Expense

$5,080,000 (4.87%)

$4,844,000 (6.60%)

$4,544,000 (5.16%)

$4,321,000 (10.23%)

Operating Expenses

$48,205,000 (-10.25%)

$53,710,000 (1.93%)

$52,693,000 (9.67%)

$48,049,000 (27.83%)

Interest Expense

$5,907,000 (138.38%)

$2,478,000 (16420.00%)

$15,000 (50.00%)

$10,000 (-78.26%)

Income Tax Expense

$252,000 (110.36%)

-$2,432,000 (-762.67%)

$367,000 (-3.42%)

$380,000 (105.06%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$23,559,000 (-24.98%)

-$18,850,000 (19.02%)

-$23,278,000 (-53.14%)

-$15,200,000 (-27.67%)

Net Income to Non-Controlling Interests

-$96,000 (29.93%)

-$137,000 (-45.74%)

-$94,000 (-235.71%)

-$28,000 (-180.00%)

Net Income

-$23,463,000 (-25.38%)

-$18,713,000 (19.28%)

-$23,184,000 (-52.81%)

-$15,172,000 (-27.54%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$23,463,000 (-25.38%)

-$18,713,000 (19.28%)

-$23,184,000 (-52.81%)

-$15,172,000 (-27.54%)

Weighted Average Shares

$35,542,000 (2.66%)

$34,622,000 (0.31%)

$34,516,000 (0.54%)

$34,332,000 (0.35%)

Weighted Average Shares Diluted

$35,542,000 (2.66%)

$34,622,000 (0.31%)

$34,516,000 (0.54%)

$34,332,000 (0.35%)

Earning Before Interest & Taxes (EBIT)

-$17,304,000 (7.30%)

-$18,667,000 (18.13%)

-$22,802,000 (-54.26%)

-$14,782,000 (23.62%)

Gross Profit

$29,360,000 (-13.03%)

$33,759,000 (15.89%)

$29,131,000 (-13.30%)

$33,601,000 (91.96%)

Operating Income

-$18,845,000 (5.54%)

-$19,951,000 (15.33%)

-$23,562,000 (-63.08%)

-$14,448,000 (28.06%)

APYX Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$722,000 (-110.72%)

$6,734,000 (766.73%)

-$1,010,000 (-39.70%)

-$723,000 (-24.44%)

Net Cash Flow from Financing

$6,745,000 (-79.03%)

$32,166,000 (14723.04%)

$217,000 (804.17%)

$24,000 (132.88%)

Net Cash Flow from Operations

-$18,047,000 (-243.82%)

-$5,249,000 (74.12%)

-$20,280,000 (-94.09%)

-$10,449,000 (34.96%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$11,911,000 (-135.60%)

$33,460,000 (261.81%)

-$20,678,000 (-87.22%)

-$11,045,000 (34.63%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$722,000 (-110.72%)

$6,734,000 (766.73%)

-$1,010,000 (-39.70%)

-$723,000 (-24.44%)

Issuance (Repayment) of Debt Securities

-$20,000 (-100.06%)

$31,933,000 (21676.35%)

-$148,000 (37.82%)

-$238,000 (35.50%)

Issuance (Purchase) of Equity Shares

$7,000,000 (8039.53%)

$86,000 (-76.44%)

$365,000 (444.78%)

$67,000 (-54.73%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$113,000 (159.16%)

-$191,000 (-148.35%)

$395,000 (283.50%)

$103,000 (158.19%)

Share Based Compensation

$4,013,000 (-21.53%)

$5,114,000 (-23.64%)

$6,697,000 (31.62%)

$5,088,000 (20.86%)

Depreciation Amortization & Accretion

$711,000 (-8.73%)

$779,000 (-12.47%)

$890,000 (-1.44%)

$903,000 (1.80%)

APYX Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

61.00% (-5.43%)

64.50% (-1.38%)

65.40% (-5.63%)

69.30% (9.65%)

Profit Margin

-48.80% (-36.69%)

-35.70% (31.48%)

-52.10% (-66.45%)

-31.30% (27.04%)

EBITDA Margin

-34.50% (-0.88%)

-34.20% (30.49%)

-49.20% (-72.03%)

-28.60% (57.06%)

Return on Average Equity (ROAE)

-155.80% (-176.24%)

-56.40% (-6.42%)

-53.00% (-97.03%)

-26.90% (-50.28%)

Return on Average Assets (ROAA)

-35.90% (-23.79%)

-29.00% (28.22%)

-40.40% (-84.47%)

-21.90% (-42.21%)

Return on Sales (ROS)

-36.00% (-0.84%)

-35.70% (30.27%)

-51.20% (-67.87%)

-30.50% (56.30%)

Return on Invested Capital (ROIC)

-28.20% (34.42%)

-43.00% (45.84%)

-79.40% (-31.02%)

-60.60% (28.45%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-2.39 (50.66%)

-4.85 (-38.91%)

-3.49 (88.01%)

-29.14 (-41.64%)

Price to Sales Ratio (P/S)

1.17 (-32.66%)

1.73 (-4.52%)

1.81 (-79.99%)

9.07 (2.06%)

Price to Book Ratio (P/B)

3.85 (13.33%)

3.4 (57.80%)

2.15 (-73.73%)

8.2 (111.67%)

Debt to Equity Ratio (D/E)

3.55 (81.42%)

1.96 (426.61%)

0.37 (35.77%)

0.27 (70.19%)

Earnings Per Share (EPS)

-0.66 (-22.22%)

-0.54 (19.40%)

-0.67 (-52.27%)

-0.44 (-25.71%)

Sales Per Share (SPS)

1.35 (-10.52%)

1.51 (17.21%)

1.29 (-8.70%)

1.41 (74.44%)

Free Cash Flow Per Share (FCFPS)

-0.53 (-1327.91%)

0.04 (106.97%)

-0.62 (-89.85%)

-0.33 (33.26%)

Book Value Per Share (BVPS)

0.4 (-48.12%)

0.77 (-29.20%)

1.09 (-30.37%)

1.56 (-16.05%)

Tangible Assets Book Value Per Share (TABVPS)

1.82 (-20.31%)

2.29 (52.60%)

1.5 (-25.07%)

2 (-7.57%)

Enterprise Value Over EBIT (EV/EBIT)

-4 (0.00%)

-4 (-33.33%)

-3 (89.29%)

-28 (-154.55%)

Enterprise Value Over EBITDA (EV/EBITDA)

-3.95 (14.85%)

-4.64 (-51.91%)

-3.06 (89.65%)

-29.52 (-166.90%)

Asset Turnover

0.73 (-9.48%)

0.81 (4.64%)

0.78 (10.86%)

0.7 (95.53%)

Current Ratio

5.26 (-4.69%)

5.52 (52.32%)

3.63 (-21.17%)

4.6 (-36.29%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$18,769,000 (-1363.91%)

$1,485,000 (106.98%)

-$21,290,000 (-90.57%)

-$11,172,000 (32.89%)

Enterprise Value (EV)

$65,571,340 (-21.02%)

$83,021,900 (24.02%)

$66,939,903 (-83.66%)

$409,783,875 (100.61%)

Earnings Before Tax (EBT)

-$23,211,000 (-9.77%)

-$21,145,000 (7.33%)

-$22,817,000 (-54.25%)

-$14,792,000 (23.75%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$16,593,000 (7.24%)

-$17,888,000 (18.36%)

-$21,912,000 (-57.88%)

-$13,879,000 (24.84%)

Invested Capital

$61,144,000 (-0.33%)

$61,349,000 (100.95%)

$30,529,000 (22.36%)

$24,951,000 (5.19%)

Working Capital

$45,719,000 (-20.66%)

$57,622,000 (85.15%)

$31,122,000 (-34.52%)

$47,532,000 (-16.52%)

Tangible Asset Value

$64,842,000 (-18.17%)

$79,240,000 (53.05%)

$51,775,000 (-24.66%)

$68,721,000 (-7.27%)

Market Capitalization

$54,737,340 (-39.69%)

$90,766,900 (12.11%)

$80,958,903 (-81.61%)

$440,286,875 (78.41%)

Average Equity

$15,062,750 (-54.60%)

$33,174,250 (-24.19%)

$43,759,500 (-22.36%)

$56,361,250 (-14.98%)

Average Assets

$65,417,000 (1.46%)

$64,474,750 (12.37%)

$57,377,750 (-17.20%)

$69,295,750 (-10.43%)

Invested Capital Average

$61,355,000 (41.37%)

$43,401,000 (51.20%)

$28,704,750 (17.69%)

$24,391,000 (6.80%)

Shares

34,643,886 (0.00%)

34,643,855 (0.13%)

34,597,822 (0.74%)

34,343,750 (0.20%)